Effect of recombinant human growth hormone therapy on blood lipid and carotid intima-media thickness in children with growth hormone deficiency
Authors:
Open Access
- 17 January 2018
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 83 (5) , 954-960
Abstract
Background: Reports on the association between growth hormone deficiency (GHD) and cardiovascular risk factors in children are limited. We aim to investigate the effect of different doses of recombinant human growth hormone (rhGH) therapy on blood lipid and carotid intima-media thickness (cIMT) in Chinese GHD children. Methods: Ninety children, including sixty isolated GHD children and thirty healthy children, were enrolled. GHD children were randomly divided into two groups (A and B) according to the rhGH dose given: group A received 0.23 mg/kg/week and group B received 0.35 mg/kg/week for 12 months. The TC, TG, LDL-C, HDL-C, and cIMT at baseline and after treatment were measured. Results: The height, weight, and height velocity improved significantly over 12 months of rhGH therapy in all GHD children. At baseline, GHD children in both the treatment groups showed significantly higher total cholesterol (TC), triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C), cIMT, and lower high-density lipoprotein-cholesterol (HDL-C) than healthy children (all P≤0.033). After the 12-month rhGH therapy, a significant decrease in the TC, TG, LDL-C, and cIMT, as well as a significant increase in the HDL-C (P≤0.046), was observed in the GHD children, with change in the group B being even more marked. Conclusions: The RhGH replacement therapy in GHD children can improve both the blood lipid profile and carotid intima-media thickness, with higher-dose rhGH therapy showing superior effects.Keywords
This publication has 40 references indexed in Scilit:
- Evaluation of left ventricular mass and function, lipid profile, and insulin resistance in Egyptian children with growth hormone deficiency: A single-center prospective case-control studyIndian Journal of Endocrinology and Metabolism, 2013
- Favorable Impacts of Growth Hormone (GH) Replacement Therapy on Atherogenic Risks in Japanese Children with GH DeficiencyClinical Pediatric Endocrinology, 2012
- Early Changes in Body Composition After Cessation of Growth Hormone Therapy in Childhood-Onset Growth Hormone DeficiencyJournal of Clinical Densitometry, 2011
- Early-onset growth hormone deficiency results in diastolic dysfunction in adult-life and is prevented by growth hormone supplementationGrowth Hormone & IGF Research, 2011
- Effects of 5 years of growth hormone (GH) replacement therapy on cardiac parameters and physical performance in adults with GH deficiencyPituitary, 2009
- Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiencyEuropean Journal of Endocrinology, 2007
- Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency: Relation to postprandial dyslipidemiaThe Journal of Pediatrics, 2004
- Changes in Bone Mineral Density, Body Composition, and Lipid Metabolism during Growth Hormone (GH) Treatment in Children with GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 1997
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976
- RADIOGRAPHIC ATLAS OF SKELETAL DEVELOPMENT OF THE HAND AND WRISTThe American Journal of the Medical Sciences, 1959